Prolia (denosumab)

pCPA File Number: 20939
Negotiation Status:
Concluded with an LOI
Indication(s):
Osteoporosis in Men
Sponsor/Manufacturer:
Amgen Canada Inc.
CDA-AMC Project Number:
SR0414-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: